Machine learning model predicts brain health improvements based on neural biomarkers

As part of its ongoing quest to advance better brain health and performance, new research led by Center for BrainHealth at The University of Texas at Dallas investigated neural biomarkers associated with improvements on a brain health index.

EMA committee recommends approvals for Lilly’s weight loss drug, Mirati’s KRAS inhibitor and more

The European Medicines Agency’s human medicines committee (CHMP) this week gave a thumbs-up to nine label expansions and eight new drugs, including Eli Lilly’s tirzepatide

November 11, 2023

On Anniversary of Roe Decision, Biden Tells Congress: ‘Let Doctors Do Their Job’

The Biden administration announced new actions to protect and defend access to abortion and other reproductive services on the 51st anniversary of the Roe v.

January 23, 2024

PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules | Psychedelic Invest

PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA)(OTCQB:PMBHF), a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo™ MDMA and novel MDXX compounds, and

November 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.